Norbert G. Riedel

CIK: 0001161662

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (5.9%)

Position reduction

Option Exercises (M)6 (35.3%)

Derivative conversions

Awards (A)6 (35.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (23.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

JAZZ

Jazz Pharmaceuticals plc

Director

ETON

Eton Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $241.39$408K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
14 shares at avg. $244.64$3K
JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
ETON
Eton Pharmaceuticals, Inc.
Jul 31, 2026
Award(A)
Common Stock
Direct
10K shares-
ETON
Eton Pharmaceuticals, Inc.
Apr 21, 2026
Exercise(M)
Direct
12.5K shares at avg. $7.31$91K
ETON
Eton Pharmaceuticals, Inc.
Apr 21, 2026
Exercise(M)
Direct
19.7K shares at avg. $8.61$169K
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2026
Sale(S)
Direct
3.4K shares at avg. $192.00$656K
JAZZ
Jazz Pharmaceuticals plc
Feb 27, 2026
Exercise(M)
Direct
3.4K shares at avg. $138.08$472K
ETON
Eton Pharmaceuticals, Inc.
Feb 3, 2026
In-the-Money(X)
Direct
30K shares at avg. $4.42$133K
ETON
Eton Pharmaceuticals, Inc.
Jan 12, 2026
Award(A)
Restricted Stock Units
Direct
7.8K shares-
ETON
Eton Pharmaceuticals, Inc.
Jan 12, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
12.2K shares-
JAZZ
Jazz Pharmaceuticals plc
Aug 8, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $111.25$201K
JAZZ
Jazz Pharmaceuticals plc
Aug 7, 2025
Award(A)
Direct
3.5K shares-
ETON
Eton Pharmaceuticals, Inc.
Jan 3, 2025
Exercise(M)
Direct
25K shares at avg. $3.47$87K
ETON
Eton Pharmaceuticals, Inc.
Jan 3, 2025
Exercise(M)
Direct
27.4K shares at avg. $3.58$98K
ETON
Eton Pharmaceuticals, Inc.
Jan 3, 2025
Exercise(M)
Direct
50K shares at avg. $3.78$189K
ETON
Eton Pharmaceuticals, Inc.
Jan 3, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
25K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,692	$241.39	$408,432	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	14	$244.64	$3,425	Direct
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
Jul 31, 2026	ETON Eton Pharmaceuticals, Inc.	Award(A) Common Stock	10,000	-	-	Direct
Apr 21, 2026	ETON Eton Pharmaceuticals, Inc.	Exercise(M)	12,500	$7.31	$91,375	Direct
Apr 21, 2026	ETON Eton Pharmaceuticals, Inc.	Exercise(M)	19,655	$8.61	$169,230	Direct
Feb 27, 2026	JAZZ Jazz Pharmaceuticals plc	Sale(S)	3,415	$192.00	$655,680	Direct
Feb 27, 2026	JAZZ Jazz Pharmaceuticals plc	Exercise(M)	3,415	$138.08	$471,543	Direct
Feb 3, 2026	ETON Eton Pharmaceuticals, Inc.	In-the-Money(X)	30,000	$4.42	$132,600	Direct
Jan 12, 2026	ETON Eton Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	7,757	-	-	Direct
Jan 12, 2026	ETON Eton Pharmaceuticals, Inc.	Award(A) Employee Stock Option (Right to Buy)	12,196	-	-	Direct
Aug 8, 2025	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	1,805	$111.25	$200,806	Direct
Aug 7, 2025	JAZZ Jazz Pharmaceuticals plc	Award(A)	3,507	-	-	Direct
Jan 3, 2025	ETON Eton Pharmaceuticals, Inc.	Exercise(M)	25,000	$3.47	$86,750	Direct
Jan 3, 2025	ETON Eton Pharmaceuticals, Inc.	Exercise(M)	27,400	$3.58	$98,092	Direct
Jan 3, 2025	ETON Eton Pharmaceuticals, Inc.	Exercise(M)	50,000	$3.78	$189,000	Direct
Jan 3, 2025	ETON Eton Pharmaceuticals, Inc.	Award(A) Employee Stock Option (Right to Buy)	25,000	-	-	Direct

1-17 of 17 transactions

About RIEDEL NORBERT G

RIEDEL NORBERT G (SEC CIK 0001161662) files insider reports with the SEC as Director of Jazz Pharmaceuticals plc (JAZZ) and Director of Eton Pharmaceuticals, Inc. (ETON).

Signal8 holds 10 ownership filings by RIEDEL NORBERT G, all Form 4s, filed between Jan 6, 2025 and Sep 2, 2026. Those filings report 17 transactions, from Jan 3, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on RIEDEL NORBERT G's filings is in DUBLIN 4.

Recent filings by RIEDEL NORBERT G

Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
Jul 31, 2026: Grant or award of ETON derivative securities (Form 4, code A).
Apr 21, 2026: Option exercises of ETON shares (2 lines, Form 4, code M).
Feb 27, 2026: Open-market sale of JAZZ shares (Form 4, code S).

Other insiders filing for Jazz Pharmaceuticals plc (JAZZ)

GALA RENEE D, President & CEO
COZADD BRUCE C, Director
Patil Neena M, EVP & Chief Legal Officer
Henderson Mary Elizabeth, SVP, Technical Operations
Smith Mark Douglas, Director
LOVE TED W, Director

How to read Form 4 transaction codes